Cargando…

A virtual experimenter to increase standardization for the investigation of placebo effects

BACKGROUND: Placebo effects are mediated by expectancy, which is highly influenced by psychosocial factors of a treatment context. These factors are difficult to standardize. Furthermore, dedicated placebo research often necessitates single-blind deceptive designs where biases are easily introduced....

Descripción completa

Detalles Bibliográficos
Autores principales: Horing, Bjoern, Newsome, Nathan D., Enck, Paul, Babu, Sabarish V., Muth, Eric R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950761/
https://www.ncbi.nlm.nih.gov/pubmed/27430476
http://dx.doi.org/10.1186/s12874-016-0185-4
_version_ 1782443603635732480
author Horing, Bjoern
Newsome, Nathan D.
Enck, Paul
Babu, Sabarish V.
Muth, Eric R.
author_facet Horing, Bjoern
Newsome, Nathan D.
Enck, Paul
Babu, Sabarish V.
Muth, Eric R.
author_sort Horing, Bjoern
collection PubMed
description BACKGROUND: Placebo effects are mediated by expectancy, which is highly influenced by psychosocial factors of a treatment context. These factors are difficult to standardize. Furthermore, dedicated placebo research often necessitates single-blind deceptive designs where biases are easily introduced. We propose a study protocol employing a virtual experimenter – a computer program designed to deliver treatment and instructions – for the purpose of standardization and reduction of biases when investigating placebo effects. METHODS: To evaluate the virtual experimenter’s efficacy in inducing placebo effects via expectancy manipulation, we suggest a partially blinded, deceptive design with a baseline/retest pain protocol (hand immersions in hot water bath). Between immersions, participants will receive an (actually inert) medication. Instructions pertaining to the medication will be delivered by one of three metaphors: The virtual experimenter, a human experimenter, and an audio/text presentation (predictor “Metaphor”). The second predictor includes falsely informing participants that the medication is an effective pain killer, or correctly informing them that it is, in fact, inert (predictor “Instruction”). Analysis will be performed with hierarchical linear modelling, with a sample size of N = 50. Results from two pilot studies are presented that indicate the viability of the pain protocol (N = 33), and of the virtual experimenter software and placebo manipulation (N = 48). DISCUSSION: It will be challenging to establish full comparability between all metaphors used for instruction delivery, and to account for participant differences in acceptance of their virtual interaction partner. Once established, the presence of placebo effects would suggest that the virtual experimenter exhibits sufficient cues to be perceived as a social agent. He could consequently provide a convenient platform to investigate effects of experimenter behavior, or other experimenter characteristics, e.g., sex, age, race/ethnicity or professional status. More general applications are possible, for example in psychological research such as bias research, or virtual reality research. Potential applications also exist for standardizing clinical research by documenting and communicating instructions used in clinical trials.
format Online
Article
Text
id pubmed-4950761
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49507612016-07-20 A virtual experimenter to increase standardization for the investigation of placebo effects Horing, Bjoern Newsome, Nathan D. Enck, Paul Babu, Sabarish V. Muth, Eric R. BMC Med Res Methodol Study Protocol BACKGROUND: Placebo effects are mediated by expectancy, which is highly influenced by psychosocial factors of a treatment context. These factors are difficult to standardize. Furthermore, dedicated placebo research often necessitates single-blind deceptive designs where biases are easily introduced. We propose a study protocol employing a virtual experimenter – a computer program designed to deliver treatment and instructions – for the purpose of standardization and reduction of biases when investigating placebo effects. METHODS: To evaluate the virtual experimenter’s efficacy in inducing placebo effects via expectancy manipulation, we suggest a partially blinded, deceptive design with a baseline/retest pain protocol (hand immersions in hot water bath). Between immersions, participants will receive an (actually inert) medication. Instructions pertaining to the medication will be delivered by one of three metaphors: The virtual experimenter, a human experimenter, and an audio/text presentation (predictor “Metaphor”). The second predictor includes falsely informing participants that the medication is an effective pain killer, or correctly informing them that it is, in fact, inert (predictor “Instruction”). Analysis will be performed with hierarchical linear modelling, with a sample size of N = 50. Results from two pilot studies are presented that indicate the viability of the pain protocol (N = 33), and of the virtual experimenter software and placebo manipulation (N = 48). DISCUSSION: It will be challenging to establish full comparability between all metaphors used for instruction delivery, and to account for participant differences in acceptance of their virtual interaction partner. Once established, the presence of placebo effects would suggest that the virtual experimenter exhibits sufficient cues to be perceived as a social agent. He could consequently provide a convenient platform to investigate effects of experimenter behavior, or other experimenter characteristics, e.g., sex, age, race/ethnicity or professional status. More general applications are possible, for example in psychological research such as bias research, or virtual reality research. Potential applications also exist for standardizing clinical research by documenting and communicating instructions used in clinical trials. BioMed Central 2016-07-18 /pmc/articles/PMC4950761/ /pubmed/27430476 http://dx.doi.org/10.1186/s12874-016-0185-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Horing, Bjoern
Newsome, Nathan D.
Enck, Paul
Babu, Sabarish V.
Muth, Eric R.
A virtual experimenter to increase standardization for the investigation of placebo effects
title A virtual experimenter to increase standardization for the investigation of placebo effects
title_full A virtual experimenter to increase standardization for the investigation of placebo effects
title_fullStr A virtual experimenter to increase standardization for the investigation of placebo effects
title_full_unstemmed A virtual experimenter to increase standardization for the investigation of placebo effects
title_short A virtual experimenter to increase standardization for the investigation of placebo effects
title_sort virtual experimenter to increase standardization for the investigation of placebo effects
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950761/
https://www.ncbi.nlm.nih.gov/pubmed/27430476
http://dx.doi.org/10.1186/s12874-016-0185-4
work_keys_str_mv AT horingbjoern avirtualexperimentertoincreasestandardizationfortheinvestigationofplaceboeffects
AT newsomenathand avirtualexperimentertoincreasestandardizationfortheinvestigationofplaceboeffects
AT enckpaul avirtualexperimentertoincreasestandardizationfortheinvestigationofplaceboeffects
AT babusabarishv avirtualexperimentertoincreasestandardizationfortheinvestigationofplaceboeffects
AT muthericr avirtualexperimentertoincreasestandardizationfortheinvestigationofplaceboeffects
AT horingbjoern virtualexperimentertoincreasestandardizationfortheinvestigationofplaceboeffects
AT newsomenathand virtualexperimentertoincreasestandardizationfortheinvestigationofplaceboeffects
AT enckpaul virtualexperimentertoincreasestandardizationfortheinvestigationofplaceboeffects
AT babusabarishv virtualexperimentertoincreasestandardizationfortheinvestigationofplaceboeffects
AT muthericr virtualexperimentertoincreasestandardizationfortheinvestigationofplaceboeffects